ARVD2

Jump to navigation Jump to search

Arrhythmogenic right ventricular dysplasia Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Arrhythmogenic right ventricular dysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X - Ray

ECG

Cardiac MRI

Echocardiogram

Other Imaging Findings

Endomyocardial biopsy

Atuopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

ARVD2 On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of ARVD2

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on ARVD2

CDC on ARVD2

ARVD2 in the news

Blogs onARVD2

Directions to Hospitals Treating Arrhythmogenic right ventricular dysplasia

Risk calculators and risk factors for ARVD2

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Arrhythmogenic right ventricular dysplasia type 2; arrhythmogenic right ventricular cardiomyopathy 2; ARVC2

Overview

Arrhythmogenic right ventricular dysplasia type 2 is a "concealed form" of ARVD. There is no change in heart size. There are no EKG changes on the resting electrocardiogram, but there may be exercise induced polymorphic ventricular tachycardia[1] This variant is associated with premature death.

Pathophysiology

Although the heart is normal in size, on pathologic examination, there are large areas of fibro-fatty replacement in the subepicardial layer of the right ventricle.

There are also abnormalities in calcium hemostasis in the myocytes which may contribute to the occurrence of ventricular arrhythmias.[2]

Genetics

This variant (600996) is associated with a mutation in the RYR2 gene (180902) on chromosome 1q42-q43.[3]

Epidemiology and Demographics

Natural History, Complications, Prognosis

This ARVD variant is associated with premature death.

Diagnosis

Symptoms

Exercise induced polymorphic VT may be present.

Electrocardiogram

There are no EKG changes on the resting electrocardiogram, but there may be exercise induced polymorphic ventricular tachycardia.

References

  1. Rampazzo A, Nava A, Erne P et-al. A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum. Mol. Genet. 1995;4 (11): 2151-4. <a href="http://hmg.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=8589694">Hum. Mol. Genet. (link)</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/8589694">Pubmed citation</a>
    .
  2. Scoote M, Williams AJ. Myocardial calcium signalling and arrhythmia pathogenesis. Biochem. Biophys. Res. Commun. 2004;322 (4): 1286-309. <a href="http://dx.doi.org/10.1016/j.bbrc.2004.08.034">doi:10.1016/j.bbrc.2004.08.034</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/15336976">Pubmed citation</a>
  3. Tiso N, Stephan DA, Nava A et-al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum. Mol. Genet. 2001;10 (3): 189-94. <a href="http://hmg.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=11159936">Hum. Mol. Genet. (link)</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/11159936">Pubmed citation</a>

CME Category::Cardiology